Skip to main content

Table 1 Relative reduction in surviving fraction of three glioma cells due to combination of irradiation and BO-1051 treatment

From: Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response

Irradiation dose (Gy)

Relative reduction (%)

 

U87MG

U251MG

GBM-3

2

41.7

42.6

40.6

4

70.4

45.6

47.0

6

74.2

47.9

64.3

8

76.3

50.0

73.9

  1. Percentage relative reduction of the observed surviving fraction (SF) compared to the expected SF (calculated on the basis of combing individual treatment component, each with respective SF value).
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us